Drawing for NEW B INNOVATION

USPTO serial 87778575

NEW B INNOVATION

Reviewed by CopyMark Law Group

Reg. 6903582Status 700Registered
Filing date
Status date
Registration date
Nov 22, 2022
Examiner
GAYNOR, BARBARA ANNE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with NEW B INNOVATION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Timothy T. Wang

Timothy T. Wang NI, WANG & MASSAND, PLLC8140 WALNUT HILL LANESUITE 500DALLAS, TX 75231

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and veterinary preparations, namely, prescription and over-the-counter medicines for the prevention and treatment of Gastrointestinal and Hepatobiliary System disease, Cardiovascular and Hematopoietic System diseases, Respiratory System diseases, Central Nervous System diseases, Musculo-Skeletal System diseases, Hormones related diseases, Oncology diseases, Genito-Urinary System diseases, Endocrine and Metabolic System diseases, Eye diseases, Ear and Mouth or Throat diseases, Skin diseases, Allergy and Immune System diseases and for the use as Contraceptive Agents; sanitary preparations for medical purposes; Whole blood, blood plasma, blood serum, red blood cells and hemoglobin solutions for medical purposes for the treatment and prevention of acute mountain sickness; Dietetic food and substances, namely, food for babies; medical plasters; Materials for medical dressings, namely, eye patches, gauze, antiseptic liquid bandages, drug delivery agents in the form of dissolvable films that facilitate the delivery of pharmaceutical preparations, hemostatic gel matrix preparations for treating wounds, antibacterial foam, hydrocolloids, alginates, hydrogels, and polysaccharide pastes, granules and beads; material for stopping teeth; dental wax; disinfectants for hygienic purposes, medical instruments and sanitary purposes; preparations for destroying vermin; fungicides and herbicidesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 22, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Nov 22, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 6, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 6, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 17, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 2, 2022ADBS1(B) BASIS DELETED; NEW BASIS REQUESTED—
Aug 2, 2022PCBGPETITION TO DIRECTOR - CHANGE BASIS - GRANTED—
Aug 1, 2022APETASSIGNED TO PETITION STAFF—
Jul 7, 2022IUCNNOTICE OF ALLOWANCE CANCELLED—
Jul 7, 2022EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Jul 7, 2022TPADTEAS PETITION TO AMEND BASIS RECEIVED—
Jan 13, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 12, 2022EX5GSOU EXTENSION 5 GRANTED—
Jan 12, 2022AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 4, 2022EXT5SOU EXTENSION 5 FILED—
Jan 4, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 2, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 30, 2021EX4GSOU EXTENSION 4 GRANTED—
Jun 30, 2021EXT4SOU EXTENSION 4 FILED—
Jun 30, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 6, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 4, 2021EX3GSOU EXTENSION 3 GRANTED—
Jan 4, 2021EXT3SOU EXTENSION 3 FILED—
Jan 4, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 2, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 30, 2020EX2GSOU EXTENSION 2 GRANTED—
Jun 30, 2020EXT2SOU EXTENSION 2 FILED—
Jun 30, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 10, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 6, 2019EX1GSOU EXTENSION 1 GRANTED—
Dec 6, 2019EXT1SOU EXTENSION 1 FILED—
Dec 6, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 17, 2019ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jul 16, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 21, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 21, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 1, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 12, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 4, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 3, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 3, 2019ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Dec 12, 2018ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Dec 11, 2018GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Dec 11, 2018GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 11, 2018CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 10, 2018DMCCDATA MODIFICATION COMPLETED—
Nov 20, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 20, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 15, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 15, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 15, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 15, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 14, 2018DOCKASSIGNED TO EXAMINER—
Mar 8, 2018AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Mar 5, 2018ALIEASSIGNED TO LIE—
Feb 20, 2018PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Feb 13, 2018MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Feb 10, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 3, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance